Fundraising FoxStemmatters
1 known investors
Find your way into Stemmatters
Sign up to see every warm intro you have to Stemmatters
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Stemmatters team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.
Founders & leadership
RA
Rui A. SousaCEORui A. Sousa is CEO of Stemmatters, a Contract Development and Manufacturing Organisation specializing in regenerative medicine and advanced therapy medicinal products. He has led the company's research and development operations, regulatory strategy, and establishment of business partnerships in the life sciences sector.
VD
Vitor DinisBoard Member & CFOVitor Dinis is a co-founder and CFO of Pathena, a venture capital firm, where he serves as a Non-Executive Board Member of portfolio companies. He holds a Master's degree in Accounting and Business Management from Oporto Accounting Institute and has held senior finance and audit roles at Arthur Andersen, Deloitte, Enabler (where he served as CFO), and Wipro Technologies.
Investors · 1
Related companies · 4
bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
PAREXELParexel is a contract research organization (CRO) providing clinical development, regulatory consulting, and market access services for biopharmaceutical companies conducting clinical trials across phases I-IV globally. The company operates with a network of offices and specialized facilities across North America, Latin America, Europe, and Asia-Pacific.
Fraunhofer IAOFraunhofer is a research organization whose Institute for Toxicology and Experimental Medicine (ITEM) conducts contract research, including cell-based in vitro inhalation methods to assess respiratory effects of aerosols and identify potentially harmful substances without animal testing. Its work supports safe product development under a safe-by-design approach.
MicrobioticaMicrobiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.
Companies working in the same space as Stemmatters.
Frequently asked questions
- What does Stemmatters do?
- Stemmatters is a Contract Development and Manufacturing Organisation (CDMO) focused on regenerative medicine, providing product and process development plus cGMP production and clinical translation of medicinal products. It supports customers with CMC activities, regulatory dossier preparation, and clinical batch release for investigational and advanced therapy medicinal products.
- Who are Stemmatters's investors?
- Stemmatters's investors include Beta Capital.